|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
Alta Global Showcases the Proven Success of its Warrior Training Program to Drive New Gym Memberships
Alta Global Group (NYSE American: MMA), a pioneering technology company dedicated to transforming the landscape of martial arts and combat sports training, highlighted the exceptional success of its partnership with SBG Ireland, spearheaded by Alta co-founder John Kavanagh. This collaboration, initiated in 2017, has transformed SBG Ireland into a top martial arts destination in Dublin and beyond. Prior to implementing the Alta Warrior Training Program, SBG Ireland, the home of renowned MMA coach John Kavanagh and Conor McGregor, struggled to attract non-professional athletes. This changed dramatically with the introduction of the Alta Warrior Training Program, which has since brought over 700 new members to the gym.
|
|
|
|
bioAffinity Technologies Reports April Sales of CyPath Lung Up 21% Over March
bioAffinity Technologies (Nasdaq: BIAF), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, reported sales of of CyPath® Lung, its noninvasive diagnostic test for the early detection of lung cancer, continue to climb, with April sales up 21% over March. Physicians outside of Texas are also signing up with the Company’s wholly owned subsidiary, Precision Pathology Laboratory Services, to order CyPath® Lung for their patients. In addition to Texas, pulmonologists in New Jersey, Pennsylvania, Michigan and North Carolina have ordered CyPath® Lung diagnostic tests for their patients with pulmonary nodules.
|
|
|
|
|
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
Zomedica Corp. (NYSE American: ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the issuance of three new patents, bolstering the intellectual property protection for its revolutionary TRUFORMA diagnostic platform. The TRUFORMA system provides veterinary professionals with reference laboratory accuracy directly at the point of care, enhancing the health management of horses and companion animals.
|
|
|
|
|
|
|
Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships with Two Leading Home-Based Diagnostic Companies
Biotricity Inc. (Nasdaq: BTCY), a groundbreaking Technology-as-a-Service (TaaS) company committed to delivering cutting-edge medical and consumer diagnostic healthcare solutions, announced the expansion of its cardiac diagnostics portfolio through strategic partnerships with a leading home-based neurology company and a leading home-based sleep apnea diagnostic company. Individuals suffering from sleep or neurological disorders have elevated risks for cardiac issues. These collaborations position Biotricity and its partners as comprehensive providers of holistic screenings, marking a significant advancement in Biotricity's mission to offer integrated healthcare solutions that address the complex needs of patients with multiple conditions.
|
|
|
|
|
BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID
BioVie Inc. (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced the grant of a clinical trial award of up to $13.1 million from the U.S. Department of Defense (DOD), awarded through the Peer Reviewed Medical Research Program (PRMRP) of the Congressionally Directed Medical Research Programs (CDMRP). The award can provide up to two years of non-dilutive funding for a Phase 2b clinical trial that will assess the Company’s anti-inflammatory and insulin sensitizer candidate, bezisterim (NE3107), for the treatment of neurological symptoms that are associated with long COVID. The Company anticipates the trial to commence by early 2025.
|
|
|
|
|
|
Small Stocks, Big Money™ Podcast
The podcast features in-depth interviews with CEO’s from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
Available on:
|
|
|
|
Upcoming Events
|
|
|
NASDAQ: LOBO - LOBO EV
4:15pm Eastern
LOBO EV, headquartered in Wuxi, China, is a pioneering OEM and ODM manufacturer and seller of electric vehicles (EVs), including e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles, tailored for various demographics, including mobility solutions for the elderly and disabled.
|
|
|
|
NASDAQ: MOB - Mobilicom
4:15pm Eastern
Mobilicom provides cybersecurity and robust solutions for drones and robotics. The Company is positioned to capture market leadership as the top end-to-end provider of hardware and software solutions in the rapidly growing defense and commercial drone and robotics market, a total addressable market expected to reach $8.5 billion by 2026.
|
|
|
|
Archived Events
|
|
|
NYSE American: CLDI - Calidi Biotherapeutics
4:15pm Eastern
Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer.
|
|
|
|
Quote of the Week
|
"Vast sums of money are being spent to gain advantages in speed."
|
|
|
— Michael Lewis, Flash Boys
|
|
|
|
|
RedChip TV
|
|
|
|
RedChip TV Highlights BIOVIE (NASDAQ: BIVI) & NASDAQ Contributor This Week
|
|
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
A look at the Random Walk theory and the unpredictability of short term price moves.
|
|
|
|
|
|
MidSouth Week in Review
The Dollar rose above its November high. Gold made a new recent high at $2400.
|
|
|
|
|
|
|
|
